SPRED 1 mutations in a neurofibromatosis clinic

Journal of Child Neurology

Volumn 25, Issue 10, 2010, Pages 1203-1209

  Muram Zborovski, Talia M ^a,b   Stevenson, David A ^a   Viskochil, David H ^a   Dries, David C ^a   Wilson, Andrew R ^b   Mao, Rong ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

Legius syndrome; neurofibromatosis type 1 (NF1); Ras pathway; SPRED1

Indexed keywords

ADOLESCENT; ADULT; ALLELE; ARTICLE; CARCINOGENESIS; CHILD; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; LEGIUS SYNDROME; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPRED1 GENE;

ADOLESCENT; ADULT; AGING; CAFE-AU-LAIT SPOTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MUTATION; NEUROFIBROMATOSIS 1; YOUNG ADULT;

EID: 77955291168     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809359540     Document Type: Article

References (23)

1. Stevenson DA, Swensen J., Viskochil DH Neurofibromatosis type 1 and other syndromes of the Ras pathway. In: Kaufmann D, ed. Neurofibromatoses: Monographs in Human Genetics. Basel: Karger; 2008: 32-45.
2. Brems H., Chmara M., Sahbatou M., et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet. 2007; 39: 1120-1126.
3. Pasmant E., Sabbagh A., Hanna N., et al. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet. 2009; 46: 425-430.
4. Spurlock G., Bennett E., Chuzhanova N., et al. SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the NF1 phenotype. J Med Genet. 2009; 46: 431-437.
5. Messiaen L., Yao S., Brems H., et al. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA. 2009; 302: 2111-2118.
6. National Institutes of Health. Neurofibromatosis: National Institutes of Health Consensus Development Conference. Arch Neurol. 1988; 45: 575-578.
7. Gutmann DH, Aylsworth A., Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997; 278: 51-57.
8. Messiaen LM, Callens T., Mortier G., et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000; 15: 541-555.
9. Friedman JM, Birch PH Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. 1997; 70: 138-143.
10. Reese MG, Harris N. Berkeley Drosophilia Genome Project. Available at: http://www.fruitfly.org/seq-tools/splice.html. Accessed April, 2009.
11. Stevenson DA, Viskochil DH, Rope AF, Carey JC Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. Clin Genet. 2006; 69: 246-253.
12. Nyström AM, Annerén G., Bondeson ML Noonan syndrome with café-au-lait spots and LEOPARD syndrome: evidence for genetic heterogeneity. Am J Hum Genet. 2003; 73 (suppl): 725.
13. Johnson JP, Golabi M., Norton ME, et al. Costello syndrome: phenotype, natural history, differential diagnosis, and possible cause. J Pediatr. 1998; 133: 441-448.
14. Lopez-Rangel E. Overlapping clinical phenotypes: the road to identifying dysmorphology signaling pathways and their associated risks. Clin Genet. 2007; 71: 43-44.
15. Diglio MC, Conti E., Sarkozy A., et al. Grouping of multiplelentigines/ LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet. 2002; 71: 389-394.
16. Tassabehji M., Strachan T., Sharland M., et al. Tandem duplication within a neurofibromatosis type I (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet. 1993; 53: 90-95.
17. Allanson JE, Upadhyaya M., Watson GH, et al. Watson syndrome: is it a subtype of type 1 neurofibromatosis ? J Med Genet. 1991; 28: 752-756.
18. Charrow J., Listernick R., Ward K. Autosomal dominant multiple café-au-lait spots and neurofibromatosis-1: evidence of non-linkage. Am J Med Genet. 1993; 45: 606-608.
19. Arnsmeier SL, Riccardi VM, Paller AS Familial multiple cafe au lait spots. Arch Dermatol. 1994; 130: 1425-1426.
20. Nyström AM, Ekvall S., Strömberg B., et al. A severe form of Noonan syndrome and autosomal dominant café-au-lait spots: evidence for different genetic origins. Acta Paediatr. 2009; 98: 693-698.
21. Abeliovich D., Gelman-Kohan Z., Silverstein S., et al. Familial cafe au lait spots: a variant of neurofibromatosis type 1. J Med Genet. 1995; 32: 985-986.
22. Brunner HG, Hulsebos T., Steijlen PM, et al. Exclusion of the neurofibromatosis 1 locus in a family with inherited cafe-au-lait spots. Am J Med Genet. 1993; 46: 472-474.
23. Wilken TC, Zenker M., Sticht H., et al. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. Am J Med Genet A. 2009; 149A: 1263-1267.